Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Scopolamine for Prevention of Postoperative Nausea and Vomiting in Sleeve Gastrectomy
IRCT20190325043107N75Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of scopolamine in postoperative nausea and vomiting (PONV), sponsored by Tabriz University of Medical Sciences. Started Jun 2026; status: recruiting.
02
Drugs
scopolamine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20190325043107N75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N75.